A Study to Evaluate LY01011 and Xgeva® in Healthy Adults

NCT04198636 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: LY01011
DRUG: Xgeva 120 MG in 1.7 ML Injection

Sponsor

Luye Pharma Group Ltd.

Collaborators

[object Object]